CCL2 and head and neck squamous cell carcinoma: Therefore, CCR4 represents an effective target for inhibiting local invasion and distant metastasis in HNSCC and circumventing the rebound phenomenon that might occur during the cessation or interruption of CCL2 neutralizing antibody therapy.